Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled “Use of Proceeds.”
Appears in 1889 contracts
Sources: Sales Agreement (Helius Medical Technologies, Inc.), Sales Agreement (Strive, Inc.), Sales Agreement (Eightco Holdings Inc.)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled “"Use of Proceeds.”"
Appears in 29 contracts
Sources: Sales Agreement (Sphere 3D Corp.), At the Market Offering Agreement (Marker Therapeutics, Inc.), Sales Agreement (Energy Fuels Inc)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled titled “Use of Proceeds.”
Appears in 18 contracts
Sources: Sales Agreement (Surrozen, Inc./De), At Market Issuance Sales Agreement (Journey Medical Corp), Sales Agreement (Brightcove Inc)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled “Use of Proceeds”.”
Appears in 16 contracts
Sources: Sales Agreement (Caledonia Mining Corp PLC), Sales Agreement (ChargePoint Holdings, Inc.), Sales Agreement (Applied Digital Corp.)
Use of Proceeds. The Company will use the Net Proceeds substantially as described in the Prospectus in the section entitled “Use of Proceeds.”
Appears in 15 contracts
Sources: At the Market Offering Sales Agreement (Global Self Storage, Inc.), At the Market Issuance Sales Agreement (Cyngn Inc.), At the Market Issuance Sales Agreement (Ault Alliance, Inc.)
Use of Proceeds. The Company will use the Net Proceeds as described in the manner specified in the Prospectus in the section entitled under “Use of Proceeds.”
Appears in 13 contracts
Sources: Equity Distribution Agreement (National Health Investors Inc), Equity Distribution Agreement (National Health Investors Inc), Equity Distribution Agreement (FIDUS INVESTMENT Corp)
Use of Proceeds. The Company will use the Net Proceeds as described in the U.S. Prospectus in the section entitled “Use of Proceeds.”
Appears in 12 contracts
Sources: Sales Agreement (Avino Silver & Gold Mines LTD), Sales Agreement (Seabridge Gold Inc), Sales Agreement (Avino Silver & Gold Mines LTD)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus Prospectuses in the section entitled “Use of Proceeds.”
Appears in 11 contracts
Sources: Sales Agreement (Standard Lithium Ltd.), Sales Agreement (Standard Lithium Ltd.), Sales Agreement (Endeavour Silver Corp)
Use of Proceeds. The Company will use the Net Proceeds in all material respects as described in the Prospectus in the section entitled “Use of Proceeds.”
Appears in 8 contracts
Sources: Sales Agreement (Aerie Pharmaceuticals Inc), Sales Agreement (Aerie Pharmaceuticals Inc), Sales Agreement (Aerie Pharmaceuticals Inc)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in under the section entitled “Use of Proceeds.”
Appears in 8 contracts
Sources: At Market Issuance Sales Agreement (OptimumBank Holdings, Inc.), At Market Issuance Sales Agreement (Strawberry Fields REIT, Inc.), At Market Issuance Sales Agreement (Bluerock Residential Growth REIT, Inc.)
Use of Proceeds. The Company will use the Net Proceeds net proceeds from the offering contemplated hereby as described in the Prospectus Prospectuses in the section entitled “Use of Proceeds.”
Appears in 7 contracts
Sources: Purchase Agreement (Cybin Inc.), Purchase Agreement (Genocea Biosciences, Inc.), Purchase Agreement (Actinium Pharmaceuticals, Inc.)
Use of Proceeds. The Company will use the Net Proceeds net proceeds as described in the Prospectus in Supplement under the section entitled “Use of Proceeds.”
Appears in 7 contracts
Sources: Securities Purchase Agreement (Disc Medicine, Inc.), Securities Purchase Agreement (Oric Pharmaceuticals, Inc.), Securities Purchase Agreement (Kura Oncology, Inc.)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section Section entitled “Use of Proceeds.”
Appears in 6 contracts
Sources: Sales Agreement (Immatics N.V.), At Market Issuance Sales Agreement (Seanergy Maritime Holdings Corp.), Sales Agreement (Immatics N.V.)
Use of Proceeds. The Company will use the Net Proceeds as described in the manner specified in the Prospectus in the section entitled under “Use of Proceeds”.”
Appears in 6 contracts
Sources: Equity Distribution Agreement (CMS Energy Corp), Equity Distribution Agreement (CMS Energy Corp), Equity Distribution Agreement (CMS Energy Corp)
Use of Proceeds. The Company will use the Net Proceeds it receives as described in the Prospectus in the section entitled “Use of Proceeds.”
Appears in 6 contracts
Sources: At Market Issuance Sales Agreement (Physicians Realty Trust), At Market Issuance Sales Agreement (Physicians Realty L.P.), At Market Issuance Sales Agreement (Physicians Realty L.P.)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in under the section caption entitled “Use of Proceeds.”
Appears in 5 contracts
Sources: Sales Agreement (CytoMed Therapeutics LTD), Sales Agreement (Inspira Technologies OXY B.H.N. LTD), Sales Agreement (NaaS Technology Inc.)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled “Use of Proceeds.”
Appears in 4 contracts
Sources: Sales Agreement (PolyPid Ltd.), Sales Agreement (Nano-X Imaging Ltd.), Sales Agreement (Nyxoah SA)
Use of Proceeds. The Company will use the Net Proceeds as described in the ATM Prospectus in the section entitled “Use of Proceeds.”
Appears in 3 contracts
Sources: Atm Sales Agreement (Fundamental Global Inc.), Atm Sales Agreement (Fundamental Global Inc.), Sales Agreement (Cartesian Therapeutics, Inc.)
Use of Proceeds. The Company will use the Net Proceeds net proceeds from the transactions contemplated hereby as described in the Prospectus in the section entitled “Use of Proceeds.”
Appears in 3 contracts
Sources: Purchase Agreement (Vaccinex, Inc.), Purchase Agreement (Polarityte, Inc.), Purchase Agreement (Alimera Sciences Inc)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus Supplement in the section entitled “Use of Proceeds.”
Appears in 3 contracts
Sources: At the Market Sales Agreement (Atlanticus Holdings Corp), Sales Agreement (BGC Partners, Inc.), Sales Agreement (BGC Partners, Inc.)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in Supplement under the section entitled “heading "Use of Proceeds".”
Appears in 3 contracts
Sources: Equity Distribution Agreement (Cybin Inc.), Equity Distribution Agreement (Cybin Inc.), Equity Distribution Agreement (Cybin Inc.)
Use of Proceeds. The Company will use the Net Proceeds as described in the section of the Prospectus in the section entitled “Use of Proceeds,” as such may be amended or supplemented from time to time.”
Appears in 2 contracts
Sources: At Market Issuance Sales Agreement (Spectrum Pharmaceuticals Inc), At Market Issuance Sales Agreement (Spectrum Pharmaceuticals Inc)
Use of Proceeds. The Company will use the Net Proceeds received as described in the Prospectus or Prospectus Supplement in the section entitled “Use of Proceeds.”
Appears in 2 contracts
Sources: At Market Issuance Sales Agreement (Sonoma Pharmaceuticals, Inc.), At the Market Issuance Sales Agreement (Oculus Innovative Sciences, Inc.)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled “Use of Proceeds.””
Appears in 2 contracts
Sources: Equity Distribution Agreement (Y-mAbs Therapeutics, Inc.), Sales Agreement (Olema Pharmaceuticals, Inc.)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus Prospectuses in the section entitled “"Use of Proceeds.”"
Appears in 2 contracts
Sources: Equity Distribution Agreement (High Tide Inc.), Equity Distribution Agreement (High Tide Inc.)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled “Use of Proceeds,” as such disclosure may be amended or supplemented from time to time.”
Appears in 2 contracts
Sources: Sales Agreement (Marathon Patent Group, Inc.), Sales Agreement (Aethlon Medical Inc)
Use of Proceeds. The Company will use the Net Proceeds as described in the manner specified in the Prospectus in under the section entitled caption “Use of Proceeds.”
Appears in 1 contract
Sources: Equity Distribution Agreement (National Health Investors Inc)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus Supplement in the section thereof entitled “"Use of Proceeds.”"
Appears in 1 contract
Use of Proceeds. The Company will use the Net Proceeds substantially as described in the Prospectus in the section entitled “"Use of Proceeds.”"
Appears in 1 contract
Sources: At the Market Issuance Sales Agreement (Flora Growth Corp.)
Use of Proceeds. The Company will use the Net Proceeds net proceeds as described in the Prospectus in the section entitled “Use of Proceeds.”
Appears in 1 contract
Sources: Sales Agreement (Orphazyme a/S)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled “Use of Proceeds.””
Appears in 1 contract
Use of Proceeds. The Company will use the Net Proceeds as described in the General Disclosure Package and the Prospectus in the section entitled “Use of Proceeds.”
Appears in 1 contract
Sources: At the Market Issuance Sales Agreement (CAI International, Inc.)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus Supplement in the section thereof entitled “Use of Proceeds.”
Appears in 1 contract
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled “Use of Proceeds.”” 20
Appears in 1 contract
Sources: Capital on Demand Sales Agreement (Pain Therapeutics Inc)
Use of Proceeds. The Company will use the Net Proceeds as described described, or as will be described, in the Prospectus in the section entitled “Use of Proceeds.”
Appears in 1 contract
Use of Proceeds. The Company will use the Net Proceeds as described in the applicable Prospectus in the section of the applicable Prospectus entitled “Use of Proceeds.”
Appears in 1 contract
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus Supplement in the section entitled “"Use of Proceeds.”"
Appears in 1 contract
Use of Proceeds. The Company will use the Net Proceeds as described in the U.S. Prospectus Supplement in the section entitled “"Use of Proceeds.”"
Appears in 1 contract
Use of Proceeds. The Company will use the Net Proceeds net proceeds from the offering as described in the Prospectus in the section entitled “Use of Proceeds.”
Appears in 1 contract
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled “Use of Proceeds.”” US-DOCS\103004889.3
Appears in 1 contract
Sources: Sales Agreement (Scynexis Inc)
Use of Proceeds. The Company will use the Net Proceeds net proceeds from the offering contemplated hereby as described in the Prospectus in the section entitled “Use of Proceeds.”
Appears in 1 contract
Use of Proceeds. The Company will intends to use the Net Proceeds as described in the Prospectus Prospectuses in the section entitled “Use of Proceeds.”
Appears in 1 contract
Use of Proceeds. The Company will use the Net Proceeds net proceeds as described in the Prospectus in Supplement under the section entitled “"Use of Proceeds.”"
Appears in 1 contract
Sources: Securities Purchase Agreement (Trillium Therapeutics Inc.)
Use of Proceeds. The Company will use the Net Proceeds as described in the U.S. Prospectus in the section Section entitled “Use of Proceeds.”
Appears in 1 contract
Sources: At the Market Issuance Agreement (Taseko Mines LTD)
Use of Proceeds. The Company will use in all material respects the Net Proceeds as described in the Prospectus in the section entitled “Use of Proceeds.”
Appears in 1 contract
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section Section entitled “"Use of Proceeds.”"
Appears in 1 contract
Sources: Sales Agreement (Energy Fuels Inc)
Use of Proceeds. The Company will use the Net Proceeds as described in the Prospectus in the section entitled “Use of Proceeds.”;
Appears in 1 contract